REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Virgin Money UK Plc 8 MAR

19 Mar 2024 11:24

RNS Number : 4368H
UBS Securities Australia Limited
19 March 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

UBS Securities Australia Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Virgin Money UK plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Virgin Money UK plc

(d) Date dealing undertaken:

08 March 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

CDI

Buy

 

4926096

4.10000 AUD

4.05000 AUD

CDI

Sell

 

4254386

4.16500 AUD

4.07000 AUD

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

19 March 2024

Contact name:

Richard Howard

Telephone number:

+44 (0)207 568 9128

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERSFEFFUELSEED
Date   Source Headline
5th Aug 20222:47 pmRNSPublication of Final Terms
5th Aug 20222:46 pmRNSPublication of Final Terms
26th Jul 20222:53 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
14th Jul 20223:43 pmRNSResult of AGM
12th Jul 20229:29 amRNSPre Stabilisation Notice - Nationwide Building Soc
24th Jun 202210:45 amRNSPublication of a Prospectus
10th Jun 20227:30 amRNSResolvability Assessment Framework
9th Jun 20224:56 pmRNSFurther re Tender Offer
25th May 20223:01 pmRNSTender Offer
20th May 202212:44 pmRNSPublication of Supplemental Prospectus
20th May 20227:00 amRNSAnnual Financial Report
16th May 20222:21 pmRNSPublication of Final Terms
26th Apr 20226:00 pmRNSPublication of Final Terms
5th Apr 20224:10 pmRNSRedemption of Notes
1st Apr 20229:00 amRNSDirectorate Change
1st Mar 20229:00 amRNSBoard Changes
25th Feb 20223:19 pmRNSPublication of a Prospectus
15th Feb 20229:23 amRNSPublication of Final Terms
15th Feb 20229:23 amRNSPublication of Final Terms
28th Jan 20228:00 amRNSBoard Changes
14th Dec 20217:00 amRNSResponse to Results of BoE Stress Test 2021
10th Dec 20211:51 pmRNSPublication of Base Prospectus
10th Dec 20211:41 pmRNSPublication of Base Prospectus
3rd Dec 20218:00 amRNSLeadership Succession
19th Nov 202111:13 amRNSPublication of Suppl.Prospcts
19th Nov 20217:00 amRNSHalf-year Report
29th Oct 20213:34 pmRNSPublication of a Prospectus
19th Oct 20217:00 amRNSPermanent Interest Bearing Shares Call Notice
11th Oct 20214:23 pmRNSPublication of Final Terms
23rd Sep 20219:00 amRNSLeadership Succession
10th Sep 20215:36 pmRNSPublication of Final Terms
22nd Jul 20212:49 pmRNSResults of AGM and Board changes
7th Jul 20211:57 pmRNSResult of Meeting
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus
16th Dec 202010:33 amRNSPublication of Final Terms
8th Dec 202012:47 pmRNSHolding(s) in Company
8th Dec 202012:46 pmRNSInitial admission - Offcl Lst

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.